Additional file 1 of Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathy

Additional file 1: Table S1. Clinical information of ARVC patients based on Task Force Criteria in 2010. Table S2. Clinical characteristics of enrolled ARVC patients and normal controls. Table S3. Counts of different biotypes. Table S4. Cell types assignment by using SingleR and manual annotation. Table S5. Current list of GWAS cardiac arrhythmia genes. Table S6. The summary of major non-cardiomyocytes subpopulations in ARVC and normal human hearts